BOTT vs. USRD

Last updated Jun 4, 2026

BOTT (Themes Humanoid Robotics ETF) and USRD (Themes US R&D Champions ETF) are both exchange-traded funds - BOTT is a Robotics fund tracking the Solactive Global Humanoid Robotics Index, while USRD is a Large Cap Blend Equities fund tracking the Solactive US R&D Champions Index. Both are passively managed. Over the past year, BOTT returned 84.77% vs 31.55% for USRD. A 0.71 correlation means they provide meaningful diversification when combined. BOTT charges 0.35%/yr vs 0.29%/yr for USRD.

Performance

BOTT vs. USRD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Themes Humanoid Robotics ETF (BOTT) and Themes US R&D Champions ETF (USRD). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BOTT achieves a 25.46% return, which is significantly higher than USRD's 19.83% return.

BOTT

• 1D: -2.12%
• 1M: 2.80%
• YTD: 25.46%
• 6M: 37.71%
• 1Y: 84.77%
• 3Y*: —
• 5Y*: —
• 10Y*: —

USRD

• 1D: -1.22%
• 1M: 13.66%
• YTD: 19.83%
• 6M: 18.09%
• 1Y: 31.55%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BOTT vs. USRD - Yearly Performance Comparison

	2026 (YTD)	2025	2024
BOTT Themes Humanoid Robotics ETF	25.46%	55.56%	10.74%
USRD Themes US R&D Champions ETF	19.83%	12.44%	10.98%

Correlation

The correlation between BOTT and USRD is 0.58, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.58
Correlation (All Time) Calculated using the full available price history since Apr 23, 2024	0.71

The correlation between BOTT and USRD shifts across timeframes, from 0.58 (1 year) to 0.71 (all time), reflecting how their relationship changes across market environments.

BOTT vs. USRD - Sectors Allocation Comparison

Sectors	BOTT	USRD
Industrials	41.2%	9.3%
Technology	17.9%	58.5%
Consumer Cyclical	12.3%	5.4%
Basic Materials	-	2.1%
Communication Services	-	7.2%
Consumer Defensive	-	1.9%
Energy	-	-
Healthcare	-	14.4%
Real Estate	-	1.1%
Utilities	-	-
Financial Services	-0.0%	-

Return for Risk

BOTT vs. USRD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BOTT

BOTT Risk / Return Rank: 58
BOTT Sharpe Ratio Rank: 68
BOTT Sortino Ratio Rank: 62
BOTT Omega Ratio Rank: 58
BOTT Calmar Ratio Rank: 55
BOTT Martin Ratio Rank: 45

USRD

USRD Risk / Return Rank: 52
USRD Sharpe Ratio Rank: 56
USRD Sortino Ratio Rank: 55
USRD Omega Ratio Rank: 53
USRD Calmar Ratio Rank: 48
USRD Martin Ratio Rank: 45

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BOTT vs. USRD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Themes Humanoid Robotics ETF (BOTT) and Themes US R&D Champions ETF (USRD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BOTT	USRD	Difference
Sharpe ratio: Return per unit of total volatility	2.30	1.89	+0.41
Sortino ratio: Return per unit of downside risk	2.95	2.63	+0.32
Omega ratio: Gain probability vs. loss probability	1.36	1.33	+0.04
Calmar ratio: Return relative to maximum drawdown	2.77	2.35	+0.42
Martin ratio: Return relative to average drawdown	7.46	7.30	+0.16
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BOTT vs. USRD - Sharpe Ratio Comparison

The current BOTT Sharpe Ratio is 2.30, which is comparable to the USRD Sharpe Ratio of 1.89. The chart below compares the historical Sharpe Ratios of BOTT and USRD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	BOTT	USRD	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.30	1.89	+0.41
Sharpe Ratio (All Time) Calculated using the full available price history	1.33	1.12	+0.21

Drawdowns

BOTT vs. USRD - Drawdown Comparison

The maximum BOTT drawdown since its inception was -30.74%, which is greater than USRD's maximum drawdown of -23.79%. Use the drawdown chart below to compare losses from any high point for BOTT and USRD.

Drawdown Indicators

	BOTT	USRD	Difference
Max Drawdown Largest peak-to-trough decline	-30.74%	-23.79%	-6.95%
Max Drawdown (1Y) Largest decline over 1 year	-30.74%	-13.49%	-17.25%
Current Drawdown Current decline from peak	-16.03%	-1.22%	-14.81%
Average Drawdown Average peak-to-trough decline	-6.76%	-3.70%	-3.06%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.40%	4.33%	+7.07%

Volatility

BOTT vs. USRD - Volatility Comparison

Themes Humanoid Robotics ETF (BOTT) has a higher volatility of 11.00% compared to Themes US R&D Champions ETF (USRD) at 5.55%. This indicates that BOTT's price experiences larger fluctuations and is considered to be riskier than USRD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BOTT	USRD	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.00%	5.55%	+5.45%
Volatility (6M) Calculated over the trailing 6-month period	31.00%	13.33%	+17.67%
Volatility (1Y) Calculated over the trailing 1-year period	37.02%	16.79%	+20.23%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	33.32%	19.24%	+14.08%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	33.32%	19.24%	+14.08%

BOTT vs. USRD - Expense Ratio Comparison

BOTT has a 0.35% expense ratio, which is higher than USRD's 0.29% expense ratio.

Dividends

BOTT vs. USRD - Dividend Comparison

BOTT's dividend yield for the trailing twelve months is around 0.11%, less than USRD's 0.35% yield.

Position	TTM	2025	2024
BOTT Themes Humanoid Robotics ETF	0.11%	0.14%	1.74%
USRD Themes US R&D Champions ETF	0.35%	0.42%	2.44%

Frequently Asked Questions

Can I hold both BOTT and USRD in my portfolio?

BOTT and USRD have a correlation of 0.58, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BOTT or USRD?

BOTT has higher volatility (11.00%) compared to USRD (5.55%). In terms of maximum drawdown, BOTT dropped -30.74% vs USRD's -23.79%.

Which ETF is better, BOTT or USRD?

On 1-year performance, BOTT leads with 84.77% vs 31.55% for USRD. On fees, USRD is cheaper at 0.29% per year. On volatility, USRD has been the lower-risk option at 5.55%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, BOTT or USRD?

Over the 1-year period, BOTT has performed better with a 84.77% return vs 31.55%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, BOTT or USRD?

USRD is cheaper with a 0.29% expense ratio, compared with 0.35% for BOTT.

Which ETF pays a higher dividend yield, BOTT or USRD?

USRD has the higher dividend yield at 0.35%, compared with 0.11% for BOTT.

What is the main difference between BOTT and USRD?

BOTT is categorized as Robotics, while USRD is Large Cap Blend Equities. BOTT tracks Solactive Global Humanoid Robotics Index, while USRD tracks Solactive US R&D Champions Index. Their fees differ too: 0.35% for BOTT and 0.29% for USRD.

Which has better risk-adjusted returns?

BOTT currently has the higher Sharpe Ratio (2.30 vs 1.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.